A New Biarylphosphine Ligand for the Pd-Catalyzed Synthesis of Diaryl Ethers under Mild Conditions

A new bulky biarylphosphine ligand (L8) has been developed that allows the Pd-catalyzed C-O cross-coupling of a wide range of aryl halides and phenols under milder conditions than previously possible. A direct correlation between the size of the ligand substituents in the 2', 4', and 6...

Full description

Bibliographic Details
Main Authors: Salvi, Luca (Contributor), Ali, Siraj Z. (Contributor), Davis, Nicole Rose (Contributor), Buchwald, Stephen Leffler (Contributor)
Other Authors: Massachusetts Institute of Technology. Department of Chemistry (Contributor)
Format: Article
Language:English
Published: American Chemical Society (ACS), 2013-11-04T17:05:49Z.
Subjects:
Online Access:Get fulltext
LEADER 01432 am a22002653u 4500
001 81974
042 |a dc 
100 1 0 |a Salvi, Luca  |e author 
100 1 0 |a Massachusetts Institute of Technology. Department of Chemistry  |e contributor 
100 1 0 |a Salvi, Luca  |e contributor 
100 1 0 |a Davis, Nicole Rose  |e contributor 
100 1 0 |a Ali, Siraj Z.  |e contributor 
100 1 0 |a Buchwald, Stephen Leffler  |e contributor 
700 1 0 |a Ali, Siraj Z.  |e author 
700 1 0 |a Davis, Nicole Rose  |e author 
700 1 0 |a Buchwald, Stephen Leffler  |e author 
245 0 0 |a A New Biarylphosphine Ligand for the Pd-Catalyzed Synthesis of Diaryl Ethers under Mild Conditions 
260 |b American Chemical Society (ACS),   |c 2013-11-04T17:05:49Z. 
856 |z Get fulltext  |u http://hdl.handle.net/1721.1/81974 
520 |a A new bulky biarylphosphine ligand (L8) has been developed that allows the Pd-catalyzed C-O cross-coupling of a wide range of aryl halides and phenols under milder conditions than previously possible. A direct correlation between the size of the ligand substituents in the 2', 4', and 6' positions of the nonphosphine containing ring and the reactivity of the derived catalyst system was observed. Specifically, the rate of coupling increased with the size of these substituents. 
520 |a National Institutes of Health (U.S.) (Grant GM58160) 
520 |a Amgen Inc. 
546 |a en_US 
655 7 |a Article 
773 |t Organic Letters